1. Home
  2. LTH vs PRAX Comparison

LTH vs PRAX Comparison

Compare LTH & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Life Time Group Holdings Inc.

LTH

Life Time Group Holdings Inc.

HOLD

Current Price

$41.83

Market Cap

9.4B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$254.33

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTH
PRAX
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4B
8.3B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
LTH
PRAX
Price
$41.83
$254.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
21
Target Price
$56.07
★ $650.00
AVG Volume (30 Days)
★ 2.5M
481.4K
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 124.32
N/A
EPS
★ 0.83
N/A
Revenue
★ $2,995,255,000.00
N/A
Revenue This Year
$12.50
N/A
Revenue Next Year
$11.97
$39,256.17
P/E Ratio
$50.57
★ N/A
Revenue Growth
★ 14.28
N/A
52 Week Low
$24.14
$154.46
52 Week High
$47.24
$392.70

Technical Indicators

Market Signals
Indicator
LTH
PRAX
Relative Strength Index (RSI) 57.76 38.28
Support Level $41.74 $237.78
Resistance Level $43.96 $356.02
Average True Range (ATR) 1.14 12.32
MACD 0.27 2.23
Stochastic Oscillator 79.16 32.24

Price Performance

Historical Comparison
LTH
PRAX

About LTH Life Time Group Holdings Inc.

Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: